FALKLAND, BC, Canada, Jan. 24 /PRNewswire-FirstCall/ -- avVaa World Health Care Products, Inc. , a biotech company offering global customers therapeutic skin and health care products, is pleased to announce it has filed its SEC form 10-QSB quarterly report containing financial and operating results for the quarter ended November 30, 2005.
For its third quarter 2005, avVaa reports a loss of $775,476 ($0.02 per share) compared to a loss of $539,635 in the comparable three months ended November 30, 2004 ($0.03 per share).
avVaa World Health Care Products CEO Jack Farley said, “While a number of inroads toward full-scale manufacturing and distribution were made during the third quarter, full commercialization of our flagship products is still in the beginning stages. Going forward, as we work toward full market launch of our primary Neuroskin products, we expect to realize revenue growth in the coming quarters as a result of progress in our secondary lines of Neuroskin pet and equine care products -- including partnership with U.S. and Canadian distributors.”
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.
avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin line of skin care products through mass, food and drug channels in the United States and globally. The Company’s secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: http://www.avvaa.com or http://www.otcfn.com/avvw .
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
For additional information on avVaa contact Jack Farley CEO / Chairman, at 1-866-772-8822 or visit: http://www.avvaa.com or http://www.otcfn.com/avvw
Investor Relations: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625
avVaa World Health Care Products
CONTACT: Jack Farley, CEO and Chairman, avVaa World Health Care Products,+1-866-772-8822; or Investor Relations: Merle Goertz (West Coast) of avVaaWorld Health Care Products, +1-604-688-2349; or Rick McCaffrey of OTCFinancial Network, +1-781-444-6100, ext. 625